Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
about
Beta-blockers in liver cirrhosisRethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionReview article: a drug therapy for the prevention of variceal haemorrhage.Evaluation of carvedilol for the treatment of portal hypertension.Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.Carvedilol in the treatment of portal hypertension.Management of varices in patients with cirrhosis.Beta-blockers in patients with advanced liver disease: Has the dust settled?Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach.Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.Carvedilol for portal hypertension in patients with cirrhosis.Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.Severe carvedilol toxicity without overdose - caution in cirrhosis.Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
P2860
Q27012922-D11230CB-9625-4F6C-A4F3-CAEE577B6D8FQ28069136-A5245A7E-95BB-4010-9E3F-7F1637D7F534Q34156200-098889A9-39A7-447A-BFAF-89FEAF6CF10BQ35637082-F7545603-F568-46EC-9B84-B6306ADB22E2Q35768938-910634B3-AEEA-48F7-920C-4E9D1F8738FEQ37849484-2B651D06-35D2-4355-AA6B-B49AC04DA1E9Q38094881-384F1E62-AFC3-4876-A319-898E93181D43Q38673738-38240D5C-5735-489F-ABC6-BA3D999B7025Q39676474-90F140EA-1E7E-4B3B-AC81-25DE85823421Q41036385-C6A416C5-E64D-4FD2-811A-7E9526245622Q41341900-DFF07EF3-8A76-4EFA-8BAA-A733046DBCE2Q43050079-6F87943B-6526-4EAB-9B6A-0C58E6641CE3Q43904253-60F03F12-A241-4C6C-9064-A81D3C3A4F5BQ43967445-4EE0BE91-0BA3-4EB7-891B-849B546DE244Q45077758-41BBD77B-B26D-4EBB-9BDB-F19B6F27E800Q45927000-99A80241-22CD-489E-B15C-39AB89D04985Q47100753-03926436-4F30-4E03-9391-29D69DFC604DQ57168135-768146B8-7911-44EA-848E-3FAE4F56AF1D
P2860
Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@en
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@nl
type
label
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@en
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@nl
prefLabel
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@en
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@nl
P2093
P1476
Acute haemodynamic changes aft ...... r, in patients with cirrhosis.
@en
P2093
E H Forrest
I A Bouchier
P304
P356
10.1016/S0168-8278(96)80296-0
P577
1996-12-01T00:00:00Z